Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)

Egypt · Delayed Price · Currency is EGP

432.93

-16.93 (-3.76%)

At close: Jul 14, 2026

145.22% (1Y)

Market Cap	7.07B +193.0%
Revenue (ttm)	2.39B +30.3%
Net Income	504.49M +25.2%
EPS	33.78 +25.2%
Shares Out	14.93M
PE Ratio	14.02
Forward PE	n/a
Dividend	16.74 (3.87%)
Ex-Dividend Date	Nov 12, 2025

Volume	34,741
Open	449.86
Previous Close	449.86
Day's Range	426.05 - 445.90
52-Week Range	174.02 - 482.14
Beta	0.27
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 1, 2026

About EGX:CPCI

Kahira Pharmaceuticals & Chemical Industries Company manufactures, packages, distributes, and trades in pharmaceutical products in Egypt and internationally. It offers various pharmaceutical dosage forms, medical preparations, cosmetics, chemicals, extracts, veterinary medicines, and pesticides. The company is also involved in support services, including combination formulations. It exports its products to Sudan, Jordan, Yemen, Iraq, Djibouti, Somalia, South Sudan, Mali, Niger, Senegal, and Libya. The company was founded in 1962 and is headquar... [Read more]

Industry Pharmaceutical Preparations

Founded 1962

Employees 1,681

Stock Exchange Egyptian Stock Exchange

Ticker Symbol CPCI

Full Company Profile

Financial Performance

In fiscal year 2025, EGX:CPCI's revenue was 2.08 billion, an increase of 52.80% compared to the previous year's 1.36 billion. Earnings were 443.72 million, an increase of 80.29%.

Financial Statements